Optimizing the Design of a Repeated Fecal Immunochemical Test Bowel Cancer Screening Programme With a Limited Endoscopy Capacity From a Health Economic Perspective.

[1]  S. Whyte,et al.  The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis , 2021, Cancer Prevention Research.

[2]  T. Matsuda,et al.  Cost‐effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score , 2020, Journal of gastroenterology and hepatology.

[3]  M. Jenkins,et al.  Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Elizabeth M. Webber,et al.  Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential , 2019, JNCI cancer spectrum.

[5]  S. Whyte,et al.  External Validation of a Colorectal Cancer Model Against Screening Trial Long-Term Follow-Up Data. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[6]  I. Soerjomataram,et al.  Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report , 2018, Gut.

[7]  S. Whyte,et al.  The association between long-term conditions and uptake of population-based screening for colorectal cancer: results from two English cohort studies , 2018, Cancer management and research.

[8]  S. Moss,et al.  Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model , 2017, British Journal of Cancer.

[9]  A. Gray,et al.  Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England , 2017, BMJ Open.

[10]  R. Steele,et al.  Can the performance of a quantitative FIT-based colorectal cancer screening programme be enhanced by lowering the threshold and increasing the interval? , 2017, Gut.

[11]  S. Moss,et al.  Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England , 2016, Gut.

[12]  E. Kuipers,et al.  Nonbleeding adenomas: Evidence of systematic false‐negative fecal immunochemical test results and their implications for screening effectiveness—A modeling study , 2016, Cancer.

[13]  U. Ladabaum,et al.  Mo1711 Sensitivity of Repeated Fecal Immunochemical Testing (FIT) Over Time: Does Each “Bite at the Apple” Stand the Same Chance? , 2016 .

[14]  E. Kuipers,et al.  Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended? , 2016, Gut.

[15]  V. Moreno,et al.  Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain , 2015, Gastroenterology research and practice.

[16]  S. Whyte,et al.  Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme , 2014, British Journal of Cancer.

[17]  E. Kuipers,et al.  Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy , 2013, Gut.

[18]  S. Whyte,et al.  Reappraisal of the options for colorectal cancer screening in England , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[19]  J. Habbema,et al.  Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening , 2012, Gut.

[20]  J. Habbema,et al.  Fecal occult blood testing when colonoscopy capacity is limited. , 2011, Journal of the National Cancer Institute.

[21]  Cathal Walsh,et al.  Bayesian Calibration of a Natural History Model with Application to a Population Model for Colorectal Cancer , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[22]  J. Wilson,et al.  Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer , 2008, Gut.

[23]  W. Atkin,et al.  Surveillance guidelines after removal of colorectal adenomatous polyps , 2002, Gut.